{"name":"Deinove","slug":"deinove","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DNV3837","genericName":"DNV3837","slug":"dnv3837","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"DNV3837","genericName":"DNV3837","slug":"dnv3837","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNUWxocS1uZjlveVdGRU85S0lMMDZ1cXZqNHVnNzRUdFZUVGFVWGVmNWtZTElMRTEwb1dlZ2FIT0tvRjlZMUJoTjgwSEtWX0l2aFdGRTgzUFROT3ZsajZEQ0RxSkQ3eDFtZWs3N3JoLWJpTURadkhLSkVYY09Kai02VXBvTUdJS2cyRkRmMlp4S0NVMXA5LVVLcm9Nc1I2R1RBTE5zUTBvckd0QWFYQWxjNFRVVlVIX0ZvSWRrWlhPTmtWT3NZR3hwejRIRDJZUlZxZ05pd0hFbEZndjBuYXllNE5yQThyckQ0dW91aEMyeEhpOWlBTEhKSQ?oc=5","date":"2026-04-07","type":"pipeline","source":"Barchart.com","summary":"Clostridium Difficile Infections Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Clostridium Difficile Infections Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveIns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNd2x0VWstOWhIYWQ5RHpINEswVGRka3RZVEtSZnBSZFg2YTJSaF91QUdka1Zna3J1TjRhX2pqSHZRMkhMUzlWREtMZWpUbWpST2w1R2NiWTR2bXFHbHc1RThLQ2d1dW8tcFBQVGlmRjhDdWVOX3VSV3RzbkZIUDViR0FuMnZ4Njg3R2wyQ0JoUW95QTNYNjBNYWFVSENoajJwTWI0bVV5T2xQQjhlZ3I1bldoeW9BTnM5eWFGOEpRVmlCdHd6MWsyRm5WbFRTVmFQWlJ2QUV3V0dBYTBBbWU1ZmJWUnlVZ24zdjcxX3hyaw?oc=5","date":"2023-05-30","type":"pipeline","source":"European Medical Journal","summary":"Clostridioides difficile Infection: Targeting an Unwelcome and Persistent Threat - European Medical Journal","headline":"Clostridioides difficile Infection: Targeting an Unwelcome and Persistent Threat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxNZmNibDJzTjlSSUlBd2dibnRCXzFGOUF3bkpUOXhMRzlzNHprdG43cy1UVXpNTUd4UHRPc2pTOTQyS1pMX0Zvek8tQnZPa0dZWnotTHNUTnc4b050RUFaa3U2UkxIQTBleTNNMUtzNm41azZFOXAyZ095dzhOMDMyQkt6aW5yU0JndHZITmNaQVY3NHIwdGhQN1VDZVJvMlBYeU1MZjFQNEtjb2Q3UUh4YVZidXF0UjhiaThjdXBIcER4ZktWa1l3X3N1M0pJajhlS05NdVhodzNEQUxsSUxnaVpINld6c2tCSDdRaG5Pb2l1WjJLeVBHUGFiSnNUamZ5dUFJWlU1X2hfNUdRaWNRUHQ3ckpabDU4aWhOQ2RQWWptQWlZOUhwdg?oc=5","date":"2020-05-04","type":"deal","source":"Business Wire","summary":"Alexis RIDEAU Appointed Chief Executive Officer of DEINOVE With the Ambition to Strengthen the Company's Strategy for Innovation and Partnerships - Business Wire","headline":"Alexis RIDEAU Appointed Chief Executive Officer of DEINOVE With the Ambition to Strengthen the Company's Strategy for In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQMWRBT3NMOGxIMHdnUXQzempXbThfUEhxT3FILXdhOWtoM0MxbXZIcnJwYnB2ZldlbF9fTGFIYjFQZzZpMDZCazlhaWcyV0FzSVV4UjZEYTR3c3lsQzE2QTFDSWctc2k3Uk5UTW0zNjJqR3Bnc3dHaXdheGhNTERFVGJB?oc=5","date":"2020-05-04","type":"pipeline","source":"Premium Beauty News","summary":"Deinove appoints Alexis Rideau as Deputy CEO - Premium Beauty News","headline":"Deinove appoints Alexis Rideau as Deputy CEO","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}